KHTRF - Knight Therapeutics Inc.'s (KHTRF) CEO Jonathan Ross Goodman on Q2 2021 Results - Earnings Call Transcript

Knight Therapeutics Inc. (KHTRF) Q2 2021 Earnings Conference Call August 13, 2021, 08:30 AM ET Company Participants Jonathan Ross Goodman - Chief Executive Officer Samira Sakhia - President, Chief Operating Officer and Director Amal Khouri - Chief Business Officer Arvind Utchanah - Chief Financial Officer Jeff Martens - VP, Commercial Conference Call Participants Douglas Miehm - RBC Capital Markets David Novak - Raymond James Antonia Borovina - Bloom Burton Endri Leno - National Bank Justin Keywood - Stifel GMP Presentation Operator Good morning, ladies and gentlemen. My name is Kathy and I will be your operator today. Welcome to Knight Therapeutics Inc. 2021 Second Quarter Financial Results Conference Call. Before turning the call over to Jonathan Ross Goodman, CEO of Knight, listeners are reminded that portions of today's discussion may, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by

For further details see:

Knight Therapeutics Inc.'s (KHTRF) CEO Jonathan Ross Goodman on Q2 2021 Results - Earnings Call Transcript